| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Renal Function Panel : 10314
Test CodeRFPAU or 10314
CPT Codes
80069
Includes
Albumin, BUN/Creatinine Ratio (calculated), Calcium, Carbon Dioxide, Chloride, Creatinine, Estimated Glomerular Filtration Rate (calculated), Glucose, Phosphate (as Phosphorus), Potassium, Sodium, Urea Nitrogen
Transport Container
Fasting specimen is preferred.
Preferred Specimen
1 mL serum
Alternative Specimen(
Spun SST® tube
Minimum Volume
0.5 mL
Preferred Specimen
1 mL serum
Alternative Specimen(
Spun SST® tube
Minimum Volume
0.5 mL
Transport Temperature
Room temperature.
Specimen Stability
Room temperature: 72 hours; Refrigerated: 72 hours; Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderate to gross hemolysis, Red-top tube (no gel), Unspun and not separated from cells, Unspun serum separator tube
Methodology
Spectrophotometry, Ion Selective Electrode
Setup Schedule
Sunday - Saturday
Report Available
1 day
Reference Range
See Laboratory Report
Clinical Significance
This panel is usually ordered to monitor patients with chronic kidney disease (CKD) or as part of a health examination for individuals at high risk of developing kidney diseases [1].
Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1]. The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involve d-pdfs/istp-ckd/laboratory-engagement-plan.pdf
Kidney disease is more likely to develop in individuals with certain conditions, such as high blood pressure, diabetes, heart disease, and a family history of kidney disease. Early symptoms of kidney diseases are often non-specific. This panel is commonly ordered during wellness checks and emergency-room admissions when symptoms and signs are suggestive of kidney diseases. National Kidney Foundation recommends a kidney profile containing estimated glomerular filtration rate and albumin-creatinine ratio for detecting and monitoring CKD [1]. The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Laboratory engagement plan: transforming kidney disease detection. National Kidney Foundation Laboratory Engagement Advisory Group. Published February 2018. Accessed January 6, 2022. https://www.ascp.org/content/docs/default-source/get-involve d-pdfs/istp-ckd/laboratory-engagement-plan.pdf
Performing Laboratory
med fusion
